发明授权
- 专利标题: Neurostimulation to treat effects of sleep apnea
- 专利标题(中): 神经刺激治疗睡眠呼吸暂停的效果
-
申请号: US10419405申请日: 2003-04-21
-
公开(公告)号: US07155278B2公开(公告)日: 2006-12-26
- 发明人: Gary W. King , Marcus J. Mianulli , Michael R. S. Hill , Thomas J. Mullen , Roy L. Testerman , John E. Burnes , Xiaohong Zhou
- 申请人: Gary W. King , Marcus J. Mianulli , Michael R. S. Hill , Thomas J. Mullen , Roy L. Testerman , John E. Burnes , Xiaohong Zhou
- 申请人地址: US MN Minneapolis
- 专利权人: Medtronic, Inc.
- 当前专利权人: Medtronic, Inc.
- 当前专利权人地址: US MN Minneapolis
- 代理商 Daniel G. Chapik; Paul H. McDowall; Girma Wolde-Michael
- 主分类号: A61N1/36
- IPC分类号: A61N1/36
摘要:
Neurostimulation is delivered to one or more predetermined locations on or within a patient in order to treat effects of sleep apnea by modulating autonomic nervous activity. Delivery of neurostimulation at predetermined locations can decrease sympathetic nervous activity and/or increase parasympathetic nervous activity, countering the increased intrinsic sympathetic activity associated with apnea-arousal cycles. In some embodiments, neurostimulation is delivered to the spinal cord of the patient via an implanted electrode. In other embodiments, neurostimulation is delivered transcutaneously to the spinal cord or other locations via electrodes located on the surface of the patient. In some embodiments, delivery of neurostimulation is initiated or modified in response to detection of apneas.
公开/授权文献
- US20040210261A1 Neurostimulation to treat effects of sleep apnea 公开/授权日:2004-10-21